Relevance of Th2 markers in the assessment and therapeutic management of severe allergic asthma: a real life perspective.

CONCLUSIONS: According to our findings blood eosinophils do not represent a univocal marker of asthma severity, whilst a higher FeNO level is associated with more frequent hospital admissions and lost working days. Blood eosinophils seem to act as predictor of treatment responsiveness to omalizumab. PMID: 30676321 [PubMed - as supplied by publisher] (Source: Journal of Investigational Allergology and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2DzZ8wU